GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation.

Int J Mol Sci · 2022 · PMC8875398 · PMID 35216409

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Thus, the German Hodgkin Study Group HD14 trial analysis with 263 patients revealed that prophylactic use of GnRH analogues as a highly significant prognostic factor for preservation of fertility favoring pregnancies [ 40 ] in early Hodgkin’s Lymphoma patients after chemotherapy treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.